Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Jun-Ho | - |
dc.contributor.author | Kim, Goo-Young | - |
dc.contributor.author | Pan, Chi-Jiunn | - |
dc.contributor.author | Anduaga, Javier | - |
dc.contributor.author | Choi, Eui-Ju | - |
dc.contributor.author | Mansfield, Brian C. | - |
dc.contributor.author | Chou, Janice Y. | - |
dc.date.accessioned | 2021-09-03T06:59:57Z | - |
dc.date.available | 2021-09-03T06:59:57Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 1553-7390 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/83695 | - |
dc.description.abstract | A deficiency in glucose-6-phosphatase-alpha (G6Pase-alpha) in glycogen storage disease type Ia (GSD-Ia) leads to impaired glucose homeostasis and metabolic manifestations including hepatomegaly caused by increased glycogen and neutral fat accumulation. A recent report showed that G6Pase-alpha deficiency causes impairment in autophagy, a recycling process important for cellular metabolism. However, the molecular mechanism underlying defective autophagy is unclear. Here we show that in mice, liver-specific knockout of G6Pase-alpha (L-G6pc-/-) leads to downregulation of sirtuin 1 (SIRT1) signaling that activates autophagy via deacetylation of autophagy-related (ATG) proteins and forkhead box O (FoxO) family of transcriptional factors which transactivate autophagy genes. Consistently, defective autophagy in G6Pase-alpha-deficient liver is characterized by attenuated expressions of autophagy components, increased acetylation of ATG5 and ATG7, decreased conjugation of ATG5 and ATG12, and reduced autophagic flux. We further show that hepatic G6Pase-alpha deficiency results in activation of carbohydrate response element-binding protein, a lipogenic transcription factor, increased expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a lipid regulator, and suppressed expression of PPAR-alpha, a master regulator of fatty acid beta-oxidation, all contributing to hepatic steatosis and downregulation of SIRT1 expression. An adenovirus vector-mediated increase in hepatic SIRT1 expression corrects autophagy defects but does not rectify metabolic abnormalities associated with G6Pase-alpha deficiency. Importantly, a recombinant adeno-associated virus (rAAV) vector-mediated restoration of hepatic G6Pase-alpha expression corrects metabolic abnormalities, restores SIRT1FoxO signaling, and normalizes defective autophagy. Taken together, these data show that hepatic G6Pase-alpha deficiency-mediated down-regulation of SIRT1 signaling underlies defective hepatic autophagy in GSD-Ia. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.subject | RAPAMYCIN MTOR | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | MAMMALIAN TARGET | - |
dc.subject | GENE-THERAPY | - |
dc.subject | PPAR-GAMMA | - |
dc.subject | OBESITY | - |
dc.subject | PHOSPHORYLATION | - |
dc.subject | DEFICIENCY | - |
dc.subject | METABOLISM | - |
dc.subject | MOUSE | - |
dc.title | Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Eui-Ju | - |
dc.identifier.doi | 10.1371/journal.pgen.1006819 | - |
dc.identifier.scopusid | 2-s2.0-85020186673 | - |
dc.identifier.wosid | 000402884800057 | - |
dc.identifier.bibliographicCitation | PLOS GENETICS, v.13, no.5 | - |
dc.relation.isPartOf | PLOS GENETICS | - |
dc.citation.title | PLOS GENETICS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 5 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.subject.keywordPlus | RAPAMYCIN MTOR | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | MAMMALIAN TARGET | - |
dc.subject.keywordPlus | GENE-THERAPY | - |
dc.subject.keywordPlus | PPAR-GAMMA | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | DEFICIENCY | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | MOUSE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.